Compare TEVA & WBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | WBD |
|---|---|---|
| Founded | 1901 | 1923 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 52.1B |
| IPO Year | N/A | N/A |
| Metric | TEVA | WBD |
|---|---|---|
| Price | $29.74 | $29.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 23 |
| Target Price | ★ $29.78 | $19.47 |
| AVG Volume (30 Days) | 10.4M | ★ 60.8M |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | 0.19 |
| Revenue | $16,776,000,000.00 | ★ $37,863,000,000.00 |
| Revenue This Year | $4.74 | N/A |
| Revenue Next Year | $0.48 | N/A |
| P/E Ratio | ★ $48.90 | $154.44 |
| Revenue Growth | ★ 0.02 | N/A |
| 52 Week Low | $12.47 | $7.52 |
| 52 Week High | $30.20 | $29.99 |
| Indicator | TEVA | WBD |
|---|---|---|
| Relative Strength Index (RSI) | 79.52 | 85.99 |
| Support Level | $28.00 | $24.05 |
| Resistance Level | $30.20 | $29.81 |
| Average True Range (ATR) | 0.65 | 0.83 |
| MACD | 0.18 | 0.52 |
| Stochastic Oscillator | 92.58 | 99.86 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Warner Bros. Discovery was formed in 2022 through the combination of WarnerMedia and Discovery Communications. In 2026, it intends to split its global networks business from its streaming and studios businesses, forming two separate companies. The streaming business includes HBO Max, which is rapidly increasing its international footprint in addition to its major presence in the US. Studios include industry leaders in both film and television, which produce movies and television series that are monetized in multiple ways, including theatrical release, sales to third parties, and feeding into Warner's own platforms. Global networks consist of basic cable networks like CNN, TNT, TBS, Discovery, HGTV, and The Food Network. The Discovery+ streaming service will remain part of global networks.